Bluefin Capital Management, LLC Ocugen, Inc. Transaction History
Bluefin Capital Management, LLC
- $1.3 Billion
- Q3 2024
A detailed history of Bluefin Capital Management, LLC transactions in Ocugen, Inc. stock. As of the latest transaction made, Bluefin Capital Management, LLC holds 30,500 shares of OCGN stock, worth $21,960. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,500Holding current value
$21,960% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding OCGN
# of Institutions
124Shares Held
78.3MCall Options Held
535KPut Options Held
523K-
Black Rock Inc. New York, NY17.9MShares$12.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.9MShares$12.2 Million0.0% of portfolio
-
State Street Corp Boston, MA15.8MShares$11.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.28MShares$4.52 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA2.45MShares$1.77 Million0.1% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $156M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...